This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland
BOOK NOW
Menu
BOOK NOW

Dr. Kathryn (Kate) Monroe, PhD
Director and Principal Scientist at Denali Therapeutics
Speaker

Agenda Sessions

  • Leveraging Human Genetics for Discovery of ATV-enabled Therapeutics for Alzheimer's Disease

    , 14:05
    View Session

At this event

Prev
Next
Phil Noble, PhD
Head of Single B Cell Antibody Discovery
UCB

See Kathryn (Kate) at Antibody Engineering & Therapeutics Europe

BOOK NOW